Add this topic to your myFT Digest for news straight to your inbox
Deal will boost Swiss group’s boost healthcare operations and provide control over drug production
Professors fear losing place as one of the world’s top research universities
London university’s well-regarded neuroscience department helped it beat rivals
UK’s largest charity reduces reliance on external fund managers
Deloitte report predicts further pressure on drugmakers
UK competition watchdog says US company exploited loophole on generic treatments
Shares leap as Welsh biotech company announces plans for third-stage trials
Truvada drug to be made available to 10,000 people at risk
Biotech company chief’s science background comes into play in face of J&J bid
Study confirms Tresiba can be safely used by diabetics with heart conditions
Drugmakers want to stick with European Medicines Agency following Brexit
World’s largest healthcare group says it is in early discussions with Swiss biotech
US FDA lifts temporary ban on patient enrolment for durvalumab
NAO calls for realistic spending targets with two-thirds of trusts in deficit
Swiss drugmaker exercises right to buy developer of a treatment for sickle cell disease
Sanofi and GSK chiefs expect efforts to continue to curb rises in the US
Plans for parliament to debate and hold non-binding votes on departmental financing
NHS managers were asked to keep closure plans ‘out of the public domain’
Loss of access to free-trade deals that the bloc has struck with 50-plus countries around the world flagged up by Open Britain
Access to Medicine Index says moderate progress made in improving access to medicine
One-off tax gain helps cushion fall in earnings
London-listed group joins with Wellcome Trust and Cancer Research UK to target funding
International Edition